0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Studies with Synthetic LH-Releasing Hormone in the Human

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Synthetic LRH was injected i.v. innormal menstruating women and in patients with various endocrine disorders, such as retarded growth, precocious onset of puberty, anovulation, secondary amenorrhea, Sheehan’s syndrome, menopause, cryptorchidism, and Klinefelter’s syndrome. A linear log dose response relationship for LH release was found after injection of 12.5, 25, and 50 µg and, for FSH release, following injection of 6, 12, and 24 µg LRH. Maximal LH responses to a given test dose of 25 µg LRH in eu- and amenorrheal women differed significantly (p < 0.05). No difference in LH peak occurrence time was noted between the two groups. In 8 out of 120 individuals, no LH release was detected, e.g., in Sheehan’s syndrome and in retarded growth. In hypogonadal and hypergonadotropic subjects, an overresponsiveness of the pituitary to LRH stimuli was noted. Overresponsiveness was also observed in a peripubertal girl. The data presented support the concept of the pituitary sensitivity to exogenous LRH depending on the degree of endogenous gonadotropin releasing hormone stimulation.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1973
          1973
          19 March 2008
          : 11
          : 6
          : 328-337
          Affiliations
          Department of Obstetrics and Gynecology, University of Ulm, Ulm
          Article
          122145 Neuroendocrinology 1973;11:328–337
          10.1159/000122145
          4145909
          © 1973 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 10
          Categories
          Paper

          Comments

          Comment on this article